Literature DB >> 422237

Large-scale production and partial purification of mouse immune interferon.

L C Osborne, J A Georgiades, H M Johnson.   

Abstract

Large-scale production of high-titered (10(2.2) to 10(4) U/ml) immune interferon (type II) was carried out in roller cultures of mouse spleen cells by using the T-cell mitogen staphylococcal enterotoxin A. Precipitation of 90% of this interferon by 55 to 80% saturated ammonium sulfate resulted in a 20-fold concentration and a two- to sixfold purification. After application of this interferon to either bovine serum albumin (BSA)-Affi-Gel 10 or hydroxylapatite columns, 100% of the interferon activity was recovered. By BSA-Affi-Gel 10 chromatography, 7% of the recovered activity was not bound, 45% was eluted with pH gradient 5 to 7, and 48% was eluted with 1 M NaCl. The pH- and salt-eluted interferons from the BSA-Affi-Gel 10 column were purified 62- and 390-fold, respectively, when compared with the starting materials. Rechromatography of the pH- and salt-eluted interferon peaks from the BSA-Affi-Gel 10 column did not alter their elution patterns. Stepwise elution of interferon from the BSA-Affi-Gel 10 columns with buffers of various pH and salt contents also resulted in greater than 300-fold purification. Specific activities of up to 2 x 10(5) U of interferon per mg of protein were attained with either elution procedure from BSA-Affi-Gel 10 columns. By hydroxylapatite chromatography, 5% of the recovered activity was not bound, 20% was eluted with a salt gradient, and 75% was eluted with 30% glycerin. Purification was 107- and 16-fold, respectively, for the two fractions. Ultrogel AcA 34 chromatography of the interferon resulted in two peaks of activity, a major one with a molecular weight of approximately 40,000 and a minor peak of molecular weight 70,000 to 90,000. Thus, by different types of chromatography, immune interferon was found to be heterogeneous.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422237      PMCID: PMC550692          DOI: 10.1128/iai.23.1.80-86.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Heterogeneity of purified mouse interferons.

Authors:  E Knight
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

2.  A microplaque reduction assay for human and mouse interferon.

Authors:  J B Campbell; T Grunberger; M A Kochman; S L White
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

3.  Purification and characterization of mouse interferon with novel affinity sorbents.

Authors:  M W Davey; E Sulkowski; W A Carter
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

4.  Differences in mouse interferons according to cell source and mode of induction.

Authors:  N Maehara; M Ho; J A Armstrong
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

5.  Chromatographic separations of alphavirus strains by hydroxylapatite.

Authors:  P B Jahrling; J L Beall
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

6.  The immunosuppressive effect of type II mouse interferon preparations on antibody production.

Authors:  G Sonnenfeld; A D Mandel; T C Merigan
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

7.  Differentiation of the immunosuppressive and antiviral effects of interferon.

Authors:  H M Johnson
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

8.  Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns.

Authors:  J De Maeyer-Guignard; M G Tovey; I Gresser; E De Maeyer
Journal:  Nature       Date:  1978-02-16       Impact factor: 49.962

9.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  Purification and characterization of human leukocyte interferon components.

Authors:  E T Törmä; K Paucker
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

View more
  17 in total

1.  Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.

Authors:  W R Fleischmann; J A Georgiades; L C Osborne; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Induction of an inhibitor of interferon action in a mouse lymphokine preparation.

Authors:  W R Fleischmann; J A Georgiades; L C Osborne; F Dianzani; H M Johnson
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture.

Authors:  P C Familletti; R McCandliss; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

4.  Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.

Authors:  H Nakajima; Y Izumi; S Sugihara; Y Satoh; S Isumi; T Gotoh; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

5.  Reduction in antiviral activity of human beta interferon by gallic acid.

Authors:  L C Osborne; J T Peeler; D L Archer
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

6.  Interleukin 2 enhances natural killer cell activity through induction of gamma interferon.

Authors:  D A Weigent; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  Cellular regulation of gamma interferon production: Lyt phenotype of the suppressor cell.

Authors:  B A Torres; J K Yamamoto; H M Johnson
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Phorbol ester replacement of helper cell and interleukin 2 requirements in gamma interferon production.

Authors:  H M Johnson; B A Torres
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells.

Authors:  H Ankel; C Krishnamurti; F Besançon; S Stefanos; E Falcoff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Interferon potentiation occurs at a pretranscriptive stage.

Authors:  L A Schwarz; W R Fleischmann
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.